Sino Biological has launched ProPure endotoxin-free recombinant proteins featuring ultra-low endotoxin levels down to 0.01 EU/mg to eliminate experimental interference in cancer research. These high-purity reagents are critical for developers building precise cell-based assays and vaccines where even trace contaminants can trigger unintended immune responses and distort efficacy data. By adopting these triple-controlled proteins, research teams can ensure reproducible results and safer clinical translation for next-generation oncology therapeutics.
Read the full article at Genetic Engineering News
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.
3
Tags
Ali NematiWritten by Ali
